Last updated: 11/03/2018 12:36:35

Study to identify and characterize bacteria causing Acute Otitis Media in South African children

GSK study ID
112135
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Identification and characterization of the bacteria causing Acute Otitis Media (AOM) episodes in HIV-positive and HIV-negative children in South Africa
Trial description: The purpose of this study is to identify and characterize the bacteria causing acute otitis media episode in HIV-positive and HIV-negative children (>=3 months to <5 years) in South Africa. Middle ear fluid sampling either by tympanocentesis or by careful sampling of spontaneous otorrhoea will be done; nasopharyngeal aspirate and urine sample will also be collected from the subjects.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Occurrence of bacterial pathogens isolated from middle ear fluid samples in HIV-positive and HIV-negative subjects.

Timeframe: Not Applicable.

Secondary outcomes:

Occurrence of bacterial serotypes.

Timeframe: Not Applicable.

Antimicrobial susceptibility of different bacteria isolated from middle ear fluid samples as assessed by standard microbiological techniques.

Timeframe: Not Applicable.

Occurrence of treatment failure of acute otitis media and of recurrent acute otitis media.

Timeframe: Not Applicable.

Occurrence of spontaneous otorrhoea.

Timeframe: Not Applicable.

Occurrence of bacteria in acute otitis media cases with treatment failure and in new acute otitis media cases without treatment therapy.

Timeframe: Not Applicable.

Occurrence of bacteria in acute otitis media cases vaccinated with a pneumococcal vaccine.

Timeframe: Not Applicable.

Frequency of concurrent respiratory viral infection coinciding with the episode of acute otitis media.

Timeframe: Not Applicable.

The comparison of above endpoints in HIV-positive and HIV-negative subjects.

Timeframe: Not Applicable.

Interventions:
Procedure/surgery: Middle ear fluid, nasopharyngeal aspirate and urine sample.
Enrollment:
265
Observational study model:
Cohort
Primary completion date:
2010-03-05
Time perspective:
Prospective
Clinical publications:
Not applicable
Medical condition
Acute otitis media
Product
GSK2647154A
Collaborators
Not applicable
Study date(s)
May 2009 to May 2010
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Female & Male
Age
3 months - 5 years
Accepts healthy volunteers
No
  • Inclusion criteria for all subjects:
  • Age: >= 3 months and < 5 years at the time of enrolment.
  • Hospitalised during the diagnosis of acute otitis media or during treatment.
  • Otitis externa or otitis media with effusion.

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
Soweto, Gauteng, South Africa, 2013
Status
Study Complete

Study documents

No study documents available.

Results overview

No study documents available

Recruitment status
Finalized
Actual primary completion date
2010-03-05
Actual study completion date
2010-03-05

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website